货号:GS40134
Cirevetmab (ZTS-00521426) is an investigational caninized monoclonal antibody classified as an immunomodulator. It is developed for veterinary use, specifically targeting a key cytokine involved in immune regulation, fibrosis, and inflammation. Its primary therapeutic goal is to modulate excessive or dysregulated immune responses in dogs, potentially for conditions where this pathway plays a central role, such as chronic inflammatory diseases or fibrotic disorders.
科技型中小企业
高新技术企业
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯